The claim that lockdowns end more lives than they save is misleading

University of Bristol
24-Mar-2021 9:20 AM EDT, by University of Bristol

Fact Check By: Dr Howard H.Z. Thom, Research Fellow in Statistical Modelling and lecturer in Health Economics at the University of Bristol Medical School: Population Health Sciences, University of Bristol

Truthfulness: Mostly False


The data shows lockdowns end more lives than they save.

Claim Publisher and Date: John Tierney, New York Post on 2021-03-22

In response to the opinion piece published in the New York Post on March 22, 2021, by John Tierney, titled, "The data shows lockdowns end more lives than they save"

The central claim of this article isn't supported by the evidence provided by the author. 

The author claims "The United States will experience more than 1 million excess deaths in the United States during the next two decades as a result of the massive “unemployment shock” last year, according to a team of researchers from Johns Hopkins and Duke, who analyzed the effects of past recessions on mortality."

The author does not provide a reference but the article is likely that of Bianchi and colleagues ( This is an excellent study but wrongly assumes that unemployment and economic losses are attributable solely to government restrictions. Evidence on which is the greater factor is limited, but the IMF, for example, used changes in travel, electricity use and unemployment insurance claims at the start of 2020 to show economic conditions deteriorated before government restrictions were introduced and began to recover before they were lifted ( It concluded that lockdowns and voluntary social distancing had a near-identical economic impact. A further preprint study found that consumer spending in Denmark and Sweden fell by similar amounts during the first wave, despite Denmark introducing a stringent lockdown and Sweden using mostly voluntary restrictions ( You could go further and compare the IMF GDP 2020 growth and WHO death rates of Sweden (-4.7%, with ~54,000 deaths per million), to those of its less lenient neighbours Denmark (-4.5% with ~33,000 deaths per million), Finland (-4.0% with ~7500 deaths per million), and Norway (-2.8%, with ~11,000 deaths per million). It seems that lockdowns save lives and protect the economy, thus preventing more deaths from economic deprivation. 

It is therefore grossly misleading to attribute the 1 million excess deaths solely to response. 

The author also claims "When the 50 states are ranked according to the stringency of their lockdown restrictions, you can see one obvious pattern: The more restrictive the state, the higher the unemployment rate. But there is no pattern in the rate of COVID-19 mortality."

This ignores the confounding effect of severity of local epidemic and the question of what would have happened if there had been no restrictions. States with more restrictions may be responding to a more severe epidemic, which would have a related impact of more severe unemployment (see response to point above). Differences in absolute mortality are meaningless on their own as they ignore important demographic effects (density, urban vs rural, age, and comorbidities) that would lead to more severe epidemics in the absence of response. As an illustration, consider my own analysis of lives saved in the UK, Ireland, Spain, Germany, and Sweden up to 22nd July, counted as the first wave of the pandemic ( Simply comparing deaths per 1000 would suggest that the UK (6/1000), Spain (6/1000) and Sweden (6/1000) did worse than Germany (1/1000) and Ireland (4/1000). However, calculating deaths prevented per thousand compared to an R0=2.7 "no mitigation" scenario tells a different story, with Ireland (40/1000) and Sweden (56/1000) saving fewer lives than the UK (58/1000), Spain (60/10000) and Germany (60/1000). These patterns are likely driven by demographics as much by stringency of response. 

Register for reporter access to contact details

Filters close

Showing results

110 of 5862
Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

Released: 23-Jun-2021 11:25 AM EDT
Half of young adults with covid-19 have persistent symptoms 6 months after
University of Bergen

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Showing results

110 of 5862